Skip to main content
Premium Trial:

Request an Annual Quote

Ronald Hart

Premium

Applied DNA Sciences appointed Ronald Hart to its board of advisors. Hart was co-founder and first chair of the board of directors for the Arkansas Science and Technology Authority, and an author of the Federal Technology Transfer Act of 1986. Two years later, he was chair of the US-USSR Emerging Leaders Conference, Science and Technology Section, and first co-chair of the Intergovernmental Task Force on Technology Transfer.

Hart, who received his PhD from the University of Illinois in 1971, held the post of distinguished professor at Cairo University, in Egypt; Moscow State University; and Guangzhou University, in China. He is also a fellow of the Gerontological Society of America, the American College of Toxicology, the Association of Clinical Scientists, and the American Association for the Advancement of Science.

Filed under

The Scan

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.

Sequencing Study Leads to Vaccine Target in Bacteria Behind Neonatal Meningitis

Researchers eBioMedicine track down potential vaccine targets with transposon sequencing on mutant bacteria causing neonatal meningitis in mouse models of the disease.

Multiple Myeloma Progression Influenced by Immune Microenvironment Expression

Researchers in NPJ Genomic Medicine compare RNA sequencing profiles of 102,207 individual cells in bone marrow samples from 18 individuals with rapid or non-progressing multiple myeloma.

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.